Two Mass. biotechs each seek $115M in IPOs as sector nears record

So far in 2018, nine biotechs headquartered in Massachusetts have successfully held public stock offerings. The filings by Neon and Translate Bio come on the eve of the BIO International convention, a closely watched annual conference being held this year in Boston.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.